Can the lack of HSP90α protein in brain normal tissue and cell lines, rationalise it as a possible therapeutic target for gliomas?

Cancer Investigation

Volumn 26, Issue 9, 2008, Pages 900-904

  Shervington, Amal ^a   Cruickshanks, Nichola ^a   Lea, Robert ^c   Roberts, Gareth ^b   Dawson, Tim ^a   Shervington, Leroy ^a  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c Royal Preston Hospital ^*

Author keywords

Expression; Gliomas; HSP90 ; Normal brain tissues

Indexed keywords

HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 ALPHA; UNCLASSIFIED DRUG; HSP90ALPHA PROTEIN, HUMAN; ISOPROTEIN;

ARTICLE; BRAIN; CONTROLLED STUDY; EMBRYO; GLIOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; ADOLESCENT; ADULT; AGED; BIOSYNTHESIS; BRAIN TUMOR; CELL LINE; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; UPREGULATION;

ADOLESCENT; ADULT; AGED; BRAIN; BRAIN NEOPLASMS; CELL LINE; FEMALE; GLIOMA; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; PROTEIN ISOFORMS; UP-REGULATION; YOUNG ADULT;

EID: 57049163087     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802087259     Document Type: Article

References (19)

1. Pearl, L.H.; Prodromou, C. Structure, function, and mechanism of the Hsp90 molecular chaperone. Adv Protein Chem 2001, 59, 157-186.
2. Csermely, P.; Schnaider, T.; Soti, C.; Prohaszka, Z.; Nardai, G. The 90-kDa Molecular Chaperone Family Structure, Function, and Clinical Applications. A Comprehensive Review Pharmacol Ther 1998, 79, 129-168.
3. Richter, K.; Buchner, J. Hsp90: Chaperoning signal transduction. J Cell Physiol 2001,188, 281-290.
4. Picard, D. Heat-shock protein 90, a chaperone for folding and regulation Cell. Mol Life Sci 2002, 59, 1640-1648.
5. Pratt, W.B.: Toft, D.O.: Regulation of signalling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med 2003, 228, 111-133.
6. Sreedhar, A.: Kalmár, E.: Csermely, P. Shen, Y. Hsp90 isoforms: functions, expression and clinical importance FEBS 2004, 562, 11-15.
7. Millson, S.: Truman, A.: Rácz, A.: Hu, B.: Panaretou, B.: Nuttall, J.: Mollapour, M.: Söti, C.: Piper, P. Expressed as the sole Hsp90 of yeast, the α and β isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90β generates sensitivity to the Hsp90 inhibitor radicicol FEBS 2007, 274, 4453-4463.
8. Gupta, R.S.: Phylogenetic analysis of the 90 kD heat shock family of protein sequences and an examination of the relationship among animals, plants, and fungi species. Mol Biol Evol 1995, 12, 1063-1073.
9. Ciocca, D.R.: Calderwood, S.K. Heat Shock Proteins in Cancer: diagnosis, prognostic predictive and treatment implications. Cell Stress and Chaperones 2005, 10, 86-103.
10. Graner, M.: Bigner, D.: Chaperone proteins and brain tumours: Potential targets and possible therapeutics. Neuro-Oncology 2005, 7, 260-277.
11. Patel, R.: Shervington, L.: Lea, R.: Shervington, A. Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma, Brain Res 2008, 1188, 173-181.
12. Eustace, B.K.: Sakurai, T.: Stewart, J.K.: Yimlamai, D.: Unger, C.: Zehetmeier, C.: Lain, B.: Torella, C.: Henning, S.W.: Beste, G.: Scroggins, B.T.: Neckers, L.: Ilag, L.L.: Jay, D.G.: Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 2004, 6, 507-514.
13. Yano, M.: Naito, Z.: Yokoyama, M.: Shiraki, Y.: Ishiwata, T.: Inokuchi, M.: Asano, G. Expression of hsp90 and cyclin D1 in human breast cancer. Cancer lett 1999, 137, 45-51.
14. Park, K.: Byun, H.: Won, M.: Yang, K.: Shin, S.: Piao, L.: Kim, J.: Yoon, W.: Junn, E.: Park, J.: Seok, J.: Hur' G.: Sustained activation of protein kinase C downregulates nuclear factor-B signaling by dissociation of IKK- and Hsp90 complex in human colonic epithelial cells Carcinogenesis 2007, 28, 71-80.
15. Pearl, L.H.: Prodromou, G.: Workman, P. The Hsp90 molecular chaperone: an open and shut case for treatment, Biochem J 2008, 410, 439-453.
16. Chen, G.: Gharib, T.: Huang, C.: Taylor, J.: Misek, D.: Kardia, S.: Giordano, T.: Iannettoni, M.: Orringer, M.: Hanash, S.: Beer, D. Discordant protein and mRNA expression in lung ddenocarcinomas. Molecular & Cellular Proteomics 2002, 1, 304-313.
17. Patel, A.: McCarthy, M.: Steitz, J. The splicing of U12-type introns can be a rate-limiting step in gene expression. EMBO 2002, 21, 3804-3815.
18. Jolly, C.: Vourc'h, C.: Robert-Nicoud, M.: Morimoto, R. Intron-independent association of splicing factors with active genes. J Cell Biol 1999, 145, 1133-1143.
19. Luo,W.: Dou, F.: Rodina, A.: Chip, S.: Kim, J.: Zhao, Q.: Moulick, K.: Aguirre, J.: Wu, N.: Greengard, P.: Chiosis. G. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies. PNAS 2007, 21, 9511-9516.